Boothbay Fund Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,042
| Closed | -$61.3K | – | 1426 |
|
|
2024
Q4 | $61.3K | Sell |
6,042
-31
| -0.5% | -$314 | ﹤0.01% | 1172 |
|
|
2024
Q3 | $75.6K | Hold |
6,073
| – | – | ﹤0.01% | 1285 |
|
|
2024
Q2 | $79K | Hold |
6,073
| – | – | ﹤0.01% | 1208 |
|
|
2024
Q1 | $138K | Buy |
6,073
+624
| +11% | +$14.1K | ﹤0.01% | 1211 |
|
|
2023
Q4 | $70.7K | Hold |
5,449
| – | – | ﹤0.01% | 1318 |
|
|
2023
Q3 | $110K | Hold |
5,449
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q2 | $146K | Buy |
5,449
+1,355
| +33% | +$36.4K | ﹤0.01% | 1329 |
|
|
2023
Q1 | $239K | Buy |
+4,094
| New | +$239K | ﹤0.01% | 1416 |
|
|
2021
Q4 | – | Sell |
-2,641
| Closed | -$231K | – | 1863 |
|
|
2021
Q3 | $231K | Buy |
2,641
+1,103
| +72% | +$96.5K | 0.01% | 1257 |
|
|
2021
Q2 | $238K | Buy |
+1,538
| New | +$238K | 0.01% | 1252 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 915 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 866 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 829 |
|
|
2019
Q3 | – | Sell |
-2,455
| Closed | -$221K | – | 752 |
|
|
2019
Q2 | $221K | Sell |
2,455
-9,569
| -80% | -$861K | 0.02% | 501 |
|
|
2019
Q1 | $1.05M | Buy |
+12,024
| New | +$1.05M | 0.1% | 163 |
|
|
2018
Q3 | – | Sell |
-1,360
| Closed | -$347K | – | 746 |
|
|
2018
Q2 | $347K | Buy |
+1,360
| New | +$347K | 0.03% | 326 |
|